Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARA | P10276 | 1/20 | 0.33 |
| ▸ | RARB | P10826 | 1/20 | 0.33 |
| ▸ | RARG | P13631 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2865163 | 0.92 | RARA (0.32) | RARARARBRARG | |
| Hydrochloric Acid SCHEMBL2863146 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL2866882 | 0.90 | RARA (0.30) | RARARARBRARG | |
| Hydrochloric Acid SCHEMBL2865107 | 0.90 | RARA (0.32) | RARARARBRARG | |
| Hydrochloric Acid SCHEMBL2871873 | 0.88 | — | — | |
| Hydrochloric Acid SCHEMBL2859915 | 0.87 | — | — | |
| Hydrochloric Acid SCHEMBL2870823 | 0.85 | RARA (0.33) | RARARARBRARG | |
| Hydrochloric Acid SCHEMBL2870135 | 0.84 | — | — | |
| Hydrochloric Acid SCHEMBL2866886 | 0.82 | RARA (0.32) | RARARARBRARG | |
| Hydrochloric Acid SCHEMBL2867548 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7834204-B2 | Fluorene derivative, transition metal compound, catalyst for olefin polymerization, and process for producing olefin polymer | MITSUI CHEMICALS, INC. (JP) | 2010-11-16 | — | — | US | disclosed |
| US-20090253876-A1 | Fluorene Derivative, Transition Metal Compound, Catalyst for Olefin Polymerization, and Process for Producing Olefin Polymer | MITSUI CHEMICALS, INC. | 2009-10-08 | — | — | US | disclosed |
| EP-1900715-A1 | FLUORENE DERIVATIVE, TRANSITION METAL COMPOUND, CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER | Mitsui Chemicals, Inc. (JP) | 2008-03-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090253876-A1 | Fluorene Derivative, Transition Metal Compound, Catalyst for Olefin Polymerization, and Process for Producing Olefin Polymer | AFF4, OR10J3, DRD1 | RARA 1835/4885RARB 2054/4885RARG 2318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.